Photic Feedback treatment of a patient diagnosed with Miller Fisher syndrome has resulted in the rapid and permanent remission of symptoms. During Photic Feedback treatment, the CD20 appeared to be slighty increased. This may have been associated with changes in humoral immunity. The present clinical observation of a single patient suggests that Photic Feedback treatment should be investigated as a possible adjunct therapy for patients who suffer from polyneuropathies, such as Miller Fisher syndrome, within a carefully controlled clinical trial.
Get full access to this article
View all access options for this article.
References
1.
ArakawaY.YoshimuraM.KobayashjS.IchihashiK.MiyaoM.MomoiM. Y., & YanagisawaM. (1993) The use of intravenous immunoglobulin in Miller Fisher Syndrome. Brain Development, 5, 231–233.
2.
ChibaA.KusunokiS.ShimizuT., & KanazawaI. (1992) Serum IgG antibody to ganglioside GQlb is a possible marker of Miller Fisher Syndrome. Annals of Neurology, 31, 677–679.
3.
DillonK. M., & MinchoffB. (1985) Positive emotional states and enhancement of the immune system. International Journal of Psychiatry in Medicine, 15, 13–18.
4.
FisherM. (1956) An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). New England Journal of Medicine, 255, 57.
5.
KameiT., & KumanoH. (1994) [The correlation between change of alpha rhythm and cellular immunity caused by photic feedback system]. [Japanese Journal of Physiology], 44(Suppl. 1), S296.
6.
KameiT.YasushiM.ChijiwaM.KumanoH.SuematsuH., & MasumuraS. (1995) [Changes in CD4 and CD8 after activation of alpha waves by photic driving response]. [Japanese Journal of Physiology], 45(Suppl. 2), S343.
7.
KubasovaT.HorvarthM.KocsisK., & FenyoM. (1995) Effect of visible light on some cellular and immune parameters. Immunology and Cell Biology, 73, 239–244.
8.
OhtsukaK.NakamuraY.TagawaY., & YukiN. (1998) Immunoadsorption therapy for Fisher syndrome associated with IgG ami-GQlb antibody. American Journal of Ophthalmology, 125, 403–406.
9.
RobertsJ. E. (1995) Visible light induced changes in the immune response through an eye-brain mechanism (photoneuroimmunology). Journal of Photochemistry and Photobiology B: Biology, 29, 3–15.
10.
TedderT. F., & EngelP. (1994) CD20: a regulator of cell-cycle progression of B lymphocytes. Immunology Today, 15, 450–454.
11.
WillsonH. J.VeitchJ.PatersonG., & KennedyP. G. E. (1993) Miller Fisher syndrome is associated with serum antibody GQlb ganglioside. Journal of Neurology, Neurosurgery, and Psychiatry, 56, 204–206.
12.
YamawakiT., & SuzukiN. (1997) Can immunoadsorption plasmapheresis be used as the first choice therapy for neuroimmunological disorders?Therapeutic Apheresis, 1, 348–352.
13.
YasushiM.SaitoS., & ChijiiwaM. (1992) [Photic drive response by brain wave feedback], [Japanese Journal of Biofeedback Research], 19, 41–48.
14.
YukiN. (1997) Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome. The Journal of Infectious Diseases, 176(Suppl. 2), S150–S153.
15.
ZifkoU.DrlicekM.SenautkaG., & GrisoldW. (1994) High dose immunoglobulin therapy is effective in the Miller Fisher Syndrome. Journal of Neurology, 241, 178–179.
